RE-BVS – Piemonte Repository

Sfoglia per AUTORE
DE MERCANTI S
Collezione AOU San Luigi di Orbassano

Items : 17

Source of medical information and behavioral seeking patterns in patients affected with Friedreich's ataxia and their caregivers: a survey study. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2022 May;43(5):3223-3229. doi: 10.1007/s10072-021-05738-6. Epub 2021 Nov 28.

2022
AOU San Luigi di Orbassano

Miele G; Lavorgna L; De Mercanti SF; Iudicello M; Abbadessa G; Matta M; Bonavita S; Clerico M; Miele G; Lavorgna L; De Mercanti SF; Iudicello M; Abbadessa G; Matta M; Bonavita S; Clerico M;

A real-world study of alemtuzumab in a cohort of Italian patients. in European journal of neurology / Eur J Neurol. 2022 Jan;29(1):257-266. doi: 10.1111/ene.15121. Epub 2021 Oct 5.

2022
AOU San Luigi di Orbassano

Russo CV; Saccà F; Frau J; Annovazzi P; Signoriello E; Bonavita S; Grasso R; Clerico M; Cordioli C; Laroni A; Capobianco M; Torri Clerici V; Sartori A; Cavalla P; Maniscalco GT; La Gioia S; Caleri F; Giugno A; Iodice R; Carotenuto A; Cocco E; Fenu G; Zaffaroni M; Baroncini D; Lus G; Gallo A; De Mercanti SF; Lapucci C; Di Francescantonio V; et alii...

MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study. in Journal of the neurological sciences / J Neurol Sci. 2021 May 15;424:117385. doi: 10.1016/j.jns.2021.117385. Epub 2021 Mar 6.

2021
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Sartori A; Frangiamore R; Laroni A; Gandoglia I; Lanzillo R; Petruzzo M; Landi D; Mataluni G; Baroncini D; Mirabella M; Nociti V; Cocco E; Lorefice L; Maniscalco GT; Curti E; Lavorgna L; Abbadessa G; Bonavita S; Lus G; Signoriello E; Cordioli C; Signori A; De Mercanti SF; Cavalla P; Costantini G; Capra R; Sormani MP; Clerico M;

Case Report: Covid-19 in Multiple Sclerosis Patients Treated With Ocrelizumab: A Case Series. in Frontiers in neurology / Front Neurol. 2021 Oct 20;12:691616. doi: 10.3389/fneur.2021.691616. eCollection 2021.

2021
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Cavalla P; Clerico M; Schillaci V; Bosa C; Alteno A; De Mercanti SF; Vercellino M;

Atypical Multiple Sclerosis Lesions or Progressive Multifocal Leukoencephalopathy Lesions: That Is the Question. in Journal of investigative medicine high impact case reports / J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620939802. doi: 10.1177/2324709620939802.

2020
AOU San Luigi di Orbassano

Matta M; Iudicello M; Gned D; De Mercanti SF; Franchin E; Clerico M;

Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved? in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics / Neurotherapeutics. 2020 Jan;17(1):200-207. doi: 10.1007/s13311-019-00776-7.

2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Sartori A; Laroni A; Frangiamore R; Gandoglia I; Lanzillo R; Petruzzo M; Landi D; Mataluni G; Baroncini D; Mirabella M; Nociti V; Lorefice L; Cocco E; Curti E; Maniscalco GT; Lavorgna L; Bonavita S; Lus G; Signoriello E; Cordioli C; Signori A; Iudicello M; De Mercanti SF; Clerico M; Cavalla P; Costantini G; Sormani MP; Capra R;

Botulinum toxin for Pisa syndrome: An MRI-, ultrasound- and electromyography-guided pilot study. in Parkinsonism & related disorders / Parkinsonism Relat Disord. 2019 May;62:231-235. doi: 10.1016/j.parkreldis.2018.11.003. Epub 2018 Nov

2019
AOU San Luigi di Orbassano

Artusi CA; Bortolani S; Merola A; Zibetti M; Busso M; De Mercanti S; Arnoffi P; Martinetto S; Gaidolfi E; Veltri A; Barbero P; Lopiano L;

Active CMV infection in two patients with multiple sclerosis treated with alemtuzumab. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2017 May;23(6):874-876. doi: 10.1177/1352458516688350. Epub 2017 Feb 1.

2017
AOU San Luigi di Orbassano

Clerico M; De Mercanti S; Artusi CA; Durelli L; Naismith RT;

Lack of CD4+ T cell percent decrease in alemtuzumab-treated multiple sclerosis patients with persistent relapses. in Journal of neuroimmunology / J Neuroimmunol. 2017 Dec 15;313:89-91. doi: 10.1016/j.jneuroim.2017.10.009. Epub 2017 Oct 17.

2017
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Clerico M; Durelli L; Novelli F; Vladic A; Annovazzi P; Cocco E; Adamec I; Habek M; Horakova D; Bardina V; Rolla S; De Mercanti SF;

Influence of cigarette smoking on ALS outcome: a population-based study. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2016 Nov;87(11):1229-1233. doi: 10.1136/jnnp-2016-313793. Epub 2016 S

2016
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Mazzini L; Mora G; Pisano F; Bottacchi E; Marinou K; Moglia C; Ilardi A; Manera U; Cammarosano S; Bersano E; De Mercanti S; Clerico M; Bertuzzo D; Cugnasco P; Solero L; Chiò A; Calvo A; Canosa A;

Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2016 Jan 21;3(1):e194. doi: 10.1212/NXI.0000000000000194. eCollect

2016
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Clerico M; Durelli L; Novelli F; Annovazzi P; Horakova D; Adamec I; Habek M; Soldo-Butkovic S; Vladic A; Cocco E; Bardina V; Cucci A; Rolla S; De Mercanti S;

Heterozygous Deletion of KLHL1/ATX8OS at the SCA8 Locus Is Unlikely Associated With Cerebellar Impairment in Humans. in Cerebellum (London, England) / Cerebellum. 2016 Apr;15(2):208-12. doi: 10.1007/s12311-015-0679-3.

2016
ASL Torino 3
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Losa S; De Marchi M; Rolando M; Iudicello M; De Mercanti S; Goel H; Giachino D; Di Gregorio E; Brusco A; Mandrile G;

Long-term follow-up of ultrasound-guided botulinum toxin-A injections for sialorrhea in neurological dysphagia. in Journal of neurology / J Neurol. 2015 Dec;262(12):2662-7. doi: 10.1007/s00415-015-7894-1. Epub 2015 Sep 26.

2015
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Durelli L; Chio' A; Calvo A; Avagnina P; Veltri A; Cucci A; De Mercanti S; Artusi CA; Tinivella M; Busso M; Barbero P; Clerico M;

Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study. in JAMA neurology / JAMA Neurol. 2014 Sep;71(9):1134-42. doi: 10.1001/jamaneurol.2014.1129.

2014
AOU San Luigi di Orbassano

Chiò A; Calvo A; Bovio G; Canosa A; Bertuzzo D; Galmozzi F; Cugnasco P; Clerico M; De Mercanti S; Bersano E; Cammarosano S; Ilardi A; Manera U; Moglia C; Sideri R; Marinou K; Bottacchi E; Pisano F; Cantello R; Mazzini L; Mora G;

Th22 cells are expanded in multiple sclerosis and are resistant to IFN-?. in Journal of leukocyte biology / J Leukoc Biol. 2014 Dec;96(6):1155-64. doi: 10.1189/jlb.5A0813-463RR. Epub 2014 Aug 5.

2014
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Durelli L; Novelli F; De Palma R; Gned D; Brusa D; Quaglino P; De Mercanti S; Bardina V; Rolla S; Clerico M;

Treatment of relapsing-remitting multiple sclerosis after 24 doses of natalizumab: evidence from an Italian spontaneous, prospective, and observational study (the TY-STOP Study). in JAMA neurology / JAMA Neurol. 2014 Aug;71(8):954-60. doi: 10.1001/jamaneurol.2014.1200.

2014
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Paolicelli D; Cavalla P; Sola P; Vitetta F; Realmuto S; Salemi G; Bianchi A; Ghezzi A; Lanzillo R; Brescia Morra V; Gned D; Piazza F; De Mercanti SF; Schiavetti I; Clerico M; Trojano M; Sormani MP; Durelli L;

Neutralizing antibodies in multiple sclerosis patients treated with 375 micrograms interferon-beta-1b. in Expert opinion on biological therapy / Expert Opin Biol Ther. 2009 Apr;9(4):387-97. doi: 10.1517/14712590902762781.

2009
AOU San Luigi di Orbassano

Durelli L; Barbero P; Cucci A; Ferrero B; Ricci A; Contessa G; De Mercanti S; Ripellino P; Lapuma D; Viglietta E; Bergui M; Versino E; Clerico M;